Rare Bone Diseases and Their Dental, Oral, and Craniofacial Manifestations

Journal of Dental Research

Volumn 93, Issue , 2014, Pages 7S-19S

  Foster, B L ^a   Ramnitz, M S ^b   Gafni, R I ^c   Burke, A B ^c   Boyce, A M ^c,d   Lee, J S ^c   Wright, J T ^e   Akintoye, S O ^f   Somerman, M J ^a,c   Collins, M T ^c  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^d CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

familial hypophosphatemic rickets; fibrous dysplasia of bone; Gorham Stout disease; hyperphosphatemic familial tumoral calcinosis; hypophosphatasia; osteogenesis imperfecta

Indexed keywords

BONE DISEASE; CAFFEY DISEASE; CALCINOSIS; FACIAL BONE; FAMILIAL HYPOPHOSPHATEMIC RICKETS; FIBROUS DYSPLASIA; GENETICS; HUMAN; HYPERPHOSPHATEMIA; HYPOPHOSPHATASIA; MOUTH DISEASE; OSTEOGENESIS IMPERFECTA; OSTEOLYSIS; PATHOLOGY; RARE DISEASE; SKULL; TOOTH DISEASE;

BONE DISEASES; CALCINOSIS; FACIAL BONES; FAMILIAL HYPOPHOSPHATEMIC RICKETS; FIBROUS DYSPLASIA OF BONE; HUMANS; HYPEROSTOSIS, CORTICAL, CONGENITAL; HYPERPHOSPHATEMIA; HYPOPHOSPHATASIA; MOUTH DISEASES; OSTEOGENESIS IMPERFECTA; OSTEOLYSIS, ESSENTIAL; RARE DISEASES; SKULL; TOOTH DISEASES;

EID: 84997908454     PISSN: 00220345     EISSN: 15440591     Source Type: Journal    
DOI: 10.1177/0022034514529150     Document Type: Article

References (62)

1. Akintoye SO Lee JS Feimster T Booher S Brahim J Kingman A. (2003). Dental characteristics of fibrous dysplasia and McCune-Albright syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 96: 275-282.
2. Akintoye SO Boyce AM Collins MT (2013). Dental perspectives in fibrous dysplasia and McCune-Albright syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol 116: e149-e155.
3. Al-Jamali J Glaum R Kassem A Voss PJ Schmelzeisen R Schon R (2012). Gorham-Stout syndrome of the facial bones: a review of pathogenesis and treatment modalities and report of a case with a rare cutaneous manifestations [sic]. Oral Surg Oral Med Oral Pathol Oral Radiol 114: e23-e29.
4. Benet-Pages A Orlik P Strom TM Lorenz-Depiereux B (2005). An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia. Hum Mol Genet 14: 385-390.
5. Berdal A Molla M Descroix V (2011). Vitamin D and oral health. In: Vitamin D. Feldman D Pike JW Adams JS, editors. San Diego, CA: Academic Press, pp. 521-532.
6. Berkseth KE Tebben PJ Drake MT Hefferan TE Jewison DE Wermers RA (2013). Clinical spectrum of hypophosphatasia diagnosed in adults. Bone 54: 21-27.
7. Burkes EJ Jr Lyles KW Dolan EA Giammara B Hanker J (1991). Dental lesions in tumoral calcinosis. J Oral Pathol Med 20: 222-227.
8. Byers PH Pyott SM (2012). Recessively inherited forms of osteogenesis imperfecta. Annu Rev Genet 46: 475-497.
9. Chaussain-Miller C Sinding C Septier D Wolikow M Goldberg M Garabedian M (2007). Dentin structure in familial hypophosphatemic rickets: benefits of vitamin D and phosphate treatment. Oral Dis 13: 482-489.
10. Christou J Johnson AR Hodgson TA (2013). Bisphosphonate-related osteonecrosis of the jaws and its relevance to children—a review. Int J Paediatr Dent 23: 330-337.
11. Collmann H Mornet E Gattenlöhner S Beck C Girschick H (2009). Neurosurgical aspects of childhood hypophosphatasia. Childs Nerv Syst 25: 217-223.
12. Devlin RD Bone HG 3rd Roodman GD (1996). Interleukin-6: a potential mediator of the massive osteolysis in patients with Gorham-Stout disease. J Clin Endocrinol Metab 81: 1893-1897.
13. Dumitrescu CE Kelly MH Khosravi A Hart TC Brahim J White KE. (2009). A case of familial tumoral calcinosis/hyperostosis-hyperphosphatemia syndrome due to a compound heterozygous mutation in GALNT3 demonstrating new phenotypic features. Osteoporos Int 20: 1273-1278.
14. Farrow EG Imel EA White KE (2011). Miscellaneous non-inflammatory musculoskeletal conditions. Hyperphosphatemic familial tumoral calcinosis (FGF23, GALNT3 and alphaKlotho). Best Pract Res Clin Rheumatol 25: 735-747.
15. Foster BL Nagatomo KJ Tso HW Tran AB Nociti FH Jr Narisawa S. (2012). Tooth root dentin mineralization defects in a mouse model of hypophosphatasia. J Bone Miner Res 28: 271-282.
16. Foster BL Nociti FH Jr Somerman MJ (2014). The rachitic tooth. Endocr Rev 35: 1-34.
17. Gal G Metzker A Garlick J Gold Y Calderon S (1994). Head and neck manifestations of tumoral calcinosis. Oral Surg Oral Med Oral Pathol 77: 158-166.
18. Gjørup H Kjaer I Sonnesen L Haubek D Beck-Nielsen SS Hintze H. (2011). Craniofacial morphology in patients with hypophosphatemic rickets: a cephalometric study focusing on differences between bone of cartilaginous and intramembranous origin. Am J Med Genet A 155:2654-2660.
19. Glass LR Dagi TF Dagi LR (2011). Papilledema in the setting of x-linked hypophosphatemic rickets with craniosynostosis. Case Rep Ophthalmol 2: 376-381.
20. Gorham LW Stout AP (1955). Massive osteolysis (acute spontaneous absorption of bone, phantom bone, disappearing bone); its relation to hemangiomatosis. J Bone Joint Surg Am 37:985-1004.
21. Hart ES Kelly MH Brillante B Chen CC Ziran N Lee JS. (2007). Onset, progression, and plateau of skeletal lesions in fibrous dysplasia and the relationship to functional outcome. J Bone Miner Res 22: 1468-1474.
22. Heyden G Kindblom LG Nielsen JM (1977). Disappearing bone disease. A clinical and histological study. J Bone Joint Surg Am 59: 57-61.
23. Hirayama T Sabokbar A Itonaga I Watt-Smith S Athanasou NA (2001). Cellular and humoral mechanisms of osteoclast formation and bone resorption in Gorham-Stout disease. J Pathol 195: 624-630.
24. Ichikawa S Imel EA Kreiter ML Yu X Mackenzie DS Sorenson AH. (2007). A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis. J Musculoskelet Neuronal Interact 7: 318-319.
25. Kato K Jeanneau C Tarp MA Benet-Pages A Lorenz-Depiereux B Bennett EP. (2006). Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation. J Biol Chem 281: 18370-18377.
26. Kelly MH Brillante B Collins MT (2008). Pain in fibrous dysplasia of bone: age-related changes and the anatomical distribution of skeletal lesions. Osteoporos Int 19: 57-63.
27. Kiran DN Anupama A (2011). Vanishing bone disease: a review. J Oral Maxillofac Surg 69: 199-203.
28. Krstevska A Gale S Blair F (2012). Tumoral calcinosis: a dental literature review and case report. Dent Update 39: 416-418, 421.
29. Kuriyama DK McElligott SC Glaser DW Thompson KS (2010). Treatment of Gorham-Stout disease with zoledronic acid and interferon-alpha: a case report and literature review. J Pediatr Hematol Oncol 32: 579-584.
30. Kuznetsov SA Cherman N Riminucci M Collins MT Robey PG Bianco P (2008). Age-dependent demise of GNAS-mutated skeletal stem cells and “normalization” of fibrous dysplasia of bone. J Bone Miner Res 23: 1731-1740.
31. Lammoglia JJ Mericq V (2009). Familial tumoral calcinosis caused by a novel FGF23 mutation: response to induction of tubular renal acidosis with acetazolamide and the non-calcium phosphate binder sevelamer. Horm Res 71: 178-184.
32. Lee JS FitzGibbon E Butman JA Dufresne CR Kushner H Weintroub S. (2002). Normal vision despite narrowing of the optic canal in fibrous dysplasia. N Engl J Med 347: 1670-1676.
33. Lowing K Aström E Oscarsson KA Söderhall S Eliasson AC (2007). Effect of intravenous pamidronate therapy on everyday activities in children with osteogenesis imperfecta. Acta Paediatr 96: 1180-1183.
34. Majorana A Bardellini E Brunelli PC Lacaita M Cazzolla AP Favia G (2010). Dentinogenesis imperfecta in children with osteogenesis imperfecta: a clinical and ultrastructural study. Int J Paediatr Dent 20: 112-118.
35. Marini JC Forlino A Cabral WA Barnes AM San Antonio JD Milgrom S. (2007). Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans. Hum Mutat 28: 209-221.
36. Martinez-Glez V Valencia M Caparros-Martin JA Aglan M Temtamy S Tenorio J. (2012). Identification of a mutation causing deficient BMP1/mTLD proteolytic activity in autosomal recessive osteogenesis imperfecta. Hum Mutat 33: 343-350.
37. Milano M Wright T Loechner KJ (2011). Dental implications of osteogenesis imperfecta: treatment with IV bisphosphonate: report of a case. Pediatr Dent 33: 349-352.
38. Millán J Narisawa S Lemire I Loisel T Boileau G Leonard P. (2008). Enzyme replacement therapy for murine hypophosphatasia. J Bone Miner Res 23: 777-787.
39. Moller G Priemel M Amling M Werner M Kuhlmey AS Delling G (1999). The Gorham-Stout syndrome (Gorham's massive osteolysis). A report of six cases with histopathological findings. J Bone Joint Surg Br 81: 501-506.
40. Mornet E (2007). Hypophosphatasia. Orphanet J Rare Dis 2: 40.
41. Mulpuri K Joseph B (2000). Intramedullary rodding in osteogenesis imperfecta. J Pediatr Orthop 20: 267-273.
42. Murthy AS (2009). X-linked hypophosphatemic rickets and craniosynostosis. J Craniofac Surg 20: 439-442.
43. Nicolaou N Agrawal Y Padman M Fernandes JA Bell MJ (2012). Changing pattern of femoral fractures in osteogenesis imperfecta with prolonged use of bisphosphonates. J Child Orthop 6: 21-27.
44. Pereira CM de Andrade CR Vargas PA Coletta RD de Almeida OP Lopes MA (2004). Dental alterations associated with X-linked hypophosphatemic rickets. J Endod 30: 241-245.
45. Reibel A Manière M Clauss F Droz D Alembik Y Mornet E. (2009). Orodental phenotype and genotype findings in all subtypes of hypophosphatasia. Orphanet J Rare Dis 4: 6.
46. Reinglas J Ramphal R Bromwich M (2011). The successful management of diffuse lymphangiomatosis using sirolimus: a case report. The Laryngoscope 121: 1851-1854.
47. Riminucci M Fisher LW Shenker A Spiegel AM Bianco P Gehron Robey P (1997). Fibrous dysplasia of bone in the McCune-Albright syndrome: abnormalities in bone formation. Am J Pathol 151: 1587-1600.
48. Riminucci M Kuznetsov SA Cherman N Corsi A Bianco P Gehron Robey P (2003). Osteoclastogenesis in fibrous dysplasia of bone: in situ and in vitro analysis of IL-6 expression. Bone 33: 434-442.
49. Rodrigues TR Georgetti AP Martins L Pereira Neto JS Foster BL Nociti FH Jr (2012). Clinical correlate: case study of identical twins with cementum and periodontal defects resulting from odontohypophosphatasia. In: Mineralized tissues in oral and craniofacial science: biological principles and clinical correlates. McCauley LK Somerman MJ, editors. Ames, IA: Wiley-Blackwell, pp 183-189.
50. Ruck J Dahan-Oliel N Montpetit K Rauch F Fassier F (2011). Fassier-Duval femoral rodding in children with osteogenesis imperfecta receiving bisphosphonates: functional outcomes at one year. J Child Orthop 5: 217-224.
51. Ruggieri P Montalti M Angelini A Alberghini M Mercuri M (2011). Gorham-Stout disease: the experience of the Rizzoli Institute and review of the literature. Skeletal Radiol 40: 1391-1397.
52. Semler O Cheung MS Glorieux FH Rauch F (2010). Wormian bones in osteogenesis imperfecta: correlation to clinical findings and genotype. Am J Med Genet A 152: 1681-1687.
53. Sillence DO Senn A Danks DM (1979). Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 16: 101-116.
54. Stanton RP Ippolito E Springfield D Lindaman L Weintroub S Leet A (2012). The surgical management of fibrous dysplasia of bone. Orphanet J Rare Dis 7(Suppl 1):S1.
55. Topaz O Shurman DL Bergman R Indelman M Ratajczak P Mizrachi M. (2004). Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis. Nat Genet 36: 579-581.
56. Urakawa I Yamazaki Y Shimada T Iijima K Hasegawa H Okawa K. (2006). Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444: 770-774.
57. van Dijk FS Cobben JM Kariminejad A Maugeri A Nikkels PG van Rijn RR. (2011). Osteogenesis imperfecta: a review with clinical examples. Mol Syndromol 2: 1-20.
58. Weinstein LS Shenker A Gejman PV Merino MJ Friedman E Spiegel AM (1991). Activating mutations of the stimulatory G protein in the McCune-Albright syndrome [see comments]. N Engl J Med 325: 1688-1695.
59. Whyte M (1994). Hypophosphatasia and the role of alkaline phosphatase in skeletal mineralization. Endocr Rev 15: 439-461.
60. Whyte MP Greenberg CR Salman NJ Bober MB McAlister WH Wenkert D. (2012). Enzyme-replacement therapy in life-threatening hypophosphatasia. N Engl J Med 366: 904-913.
61. Yamaguchi T Sugimoto T Imai Y Fukase M Fujita T Chihara K (1995). Successful treatment of hyperphosphatemic tumoral calcinosis with long-term acetazolamide. Bone 16(4 Suppl):247S-250S.
62. Young JW Galbraith M Cunningham J Roof BS Vujic I Gobien RP. (1983). Progressive vertebral collapse in diffuse angiomatosis. Metab Bone Dis Relat Res 5: 53-60.